Novo Holdings and Healthcap launch new biotech firm

Novo Holdings is playing a crucial role in the establishment of the new biotech firm Tribune Therapeutics which will exploit a new pan-antifibrotic mechanism across a wide range of indications.
Photo: Novo Holdings / PR
Photo: Novo Holdings / PR
BY ANDREAS LØNSTRUP, TRANSLATED BY NIELSINE NIELSEN

Holdings company Novo Nordisk has established a new biotech firm, Tribune Therapeutics, according to a company press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading